EliseApril StrChongMD

Hematologic Oncology

Physician

Dr. Chong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Civic Center Blvd
Philadelphia, PA 19104
Phone+1 215-662-4000

Fax+1 215-662-4381

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2016 - 2019
University of Pennsylvania Health SystemResidency, Internal Medicine, 2013 - 2016
Perelman School of Medicine at the University of PennsylvaniaClass of 2013

PubMed

1 citations
Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration.
Nektarios Kostopoulos, Francesca Costabile, Elisavet Krimitza, Silvia Beghi, Denisa Goia
Blood Advances. 2024-12-24
Immune checkpoint inhibition and CAR T-cells: no longer exhausted?
Janna Minehart, Elise A Chong
Transplantation and Cellular Therapy. 2024-12-01
Identification of a clinicopathologic prognostic index for newly diagnosed large B cell lymphoma patients treated with R-CHOP.
Vincent Ni, Sunita D Nasta, Stefan K Barta, Stephen J Schuster, Elise A Chong
Haematologica. 2024-11-28

Abstracts/Posters

A Characterization of Bridging Therapies Leading up to Commercial CAR T-Cell Therapy
Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Identification and Validation of Predictive Biomarkers to CD19- and BCMA-Specific CAR T-Cell Responses in CAR T-Cell Precursors
Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Hospitalization Patterns with Commercial CAR T-Cell Therapy: A Single Institution Experience
Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Pembrolizumab and Copanlisib for the Treatment of Relapsed or Refractory Mature T-Cell Lymphomas
Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Use of Bendamustine for Lymphodepletion before Tisagenlecleucel (anti-CD19 CAR T cells) for Aggressive B-Cell Lymphomas
Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Outcomes for Double Hit Lymphoma Patients Identified Via Routine Vs Selective Testing for MYC Rearrangement
Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
Elise A. Chong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Lectures

CD19-Directed CAR T-Cell (CTL019) Product Viability and Clinical Outcomes in Non-Hodgkin Lymphomas and B-Cell Acute Lymphoblastic Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018